Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT010 vs PT003 vs PT009 vs Symbicort in COPD
CTR20160486Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Breztri Aerosphere, BEVESPI AEROSPHERE, budesonide + formoterol fumarate, budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Feb 2017; status: completed.
02
Drugs
Breztri AerosphereBEVESPI AEROSPHEREbudesonide + formoterol fumaratebudesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20160486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160486.